SmallCap Sentinel: Breakthroughs & Breakouts, Recent Stem Cell Discoveries Multiply Interest


IRVINE, Calif., May 24, 2005 (PRIMEZONE) -- "Recently published reports on what appears to be dramatic breakthroughs in stem cell research has driven interest in the field and public companies focusing on this biotechnology sector," stated SmallCap Sentinel analyst, D.R. Clark.

Shares of companies entrenched in the stem cell research field rose Friday after reports from the South Korean team that cloned the first human embryo to use for research announced that they had utilized the same technology to generate batches of embryonic stem cells from nine patients. Companies focused on stem cell development include Stemcells Inc. (Nasdaq:STEM), Aastrom Biosciences Inc. (Nasdaq:ASTM), New Life Scientific (OTCBB:NWLF) and Geron Corp. (Nasdaq:GERN).

Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.

The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid been paid thirty-six hundred dollars for preparation and distribution of this report and other advertising services by Emerging Markets Consulting LLC. Additionally, MP and/or its affiliates, associates and employees from time to time may have either a long or short position in any securities mentioned. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.



            

Contact Data